Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-16 5:32 pm Purchase | 2024-08-08 | 13G | Expion360 Inc. XPON | Altium Capital Management LLC | 150,000 9.990% | 150,000 (New Position) | Filing History |
| 2024-08-09 4:56 pm Purchase | 2024-08-05 | 13G | LogicMark, Inc. LGMK | Altium Capital Management LLC | 95,411 9.990% | 95,411 (New Position) | Filing History |
| 2024-08-09 4:52 pm Purchase | 2024-07-30 | 13G | SRx Health Solutions Inc. SRXH | Altium Capital Management LLC | 345,000 5.800% | 345,000 (New Position) | Filing History |
| 2024-05-08 6:02 pm Purchase | 2024-05-01 | 13G | Cemtrex, Inc. CETX | Altium Capital Management LLC | 67 9.990% | 67 (New Position) | Filing History |
| 2024-02-21 4:28 pm Purchase | 2024-02-13 | 13G | Sunshine Biopharma, Inc. SBFM | Altium Capital Management LLC | 4,500 9.990% | 4,500 (New Position) | Filing History |
| 2024-02-20 4:38 pm Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | Altium Capital Management LLC | 153,186 9.700% | 153,186 (New Position) | Filing History |
| 2024-02-13 5:19 pm Purchase | 2023-12-31 | 13G | Empery Digital Inc. EMPD | Altium Capital Management LLC | 1,666,665 9.900% | 1,666,665 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Altium Capital Management LLC | 18,132 4.990% | 18,132 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 5,743 4.990% | 4,923 (+600.00%) | Filing History |
| 2024-02-13 5:15 pm Unchanged | 2023-12-31 | 13G | Marpai, Inc. MRAI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:10 pm Purchase | 2023-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 8,027,593 6.200% | 1,529,675 (+23.54%) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 809 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-13 3:27 pm Sale | 2023-12-31 | 13G | Alimera Sciences, Inc. ALIM | Altium Capital Management LLC | 2,660,000 5.000% | -324,803 (-10.88%) | Filing History |
| 2024-02-02 6:09 pm Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | Altium Capital Management LLC | 1,301,518 5.400% | 1,301,518 (New Position) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 809 8.000% | 809 (New Position) | Filing History |
| 2023-11-22 5:31 pm Purchase | 2023-11-16 | 13G | Empery Digital Inc. EMPD | Altium Capital Management LLC | 2,800,000 9.900% | 2,800,000 (New Position) | Filing History |
| 2023-08-23 06:01 am Purchase | 2023-08-15 | 13G | Alimera Sciences, Inc. ALIM | Altium Capital Management LLC | 2,984,803 5.700% | 2,984,803 (New Position) | Filing History |
| 2023-05-02 8:23 pm Purchase | 2023-04-24 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 820 9.990% | 820 (New Position) | Filing History |
| 2023-04-26 5:18 pm Purchase | 2023-04-17 | 13G | Marpai, Inc. MRAI | Altium Capital Management LLC | 451,332 6.200% | 451,332 (New Position) | Filing History |
| 2023-02-14 4:51 pm Unchanged | 2022-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 6,497,918 5.700% | 0 (Unchanged) | Filing History |